4.5 Article

Isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones as unique, potent and selective inhibitors for Pim-1 and Pim-2 kinases:: Chemistry, biological activities, and molecular modeling

期刊

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 18, 期 19, 页码 5206-5208

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2008.08.079

关键词

Pim-1 kinase inhibitors; Pim-2 kinase inhibitors

向作者/读者索取更多资源

A series of isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones were synthesized as potent inhibitors against Pim-1 and Pim-2 kinases. The structure-activity-relationship studies started from a high-throughput screening hit and was guided by molecular modeling of inhibitors in the active site of Pim-1 kinase. Installing a hydroxyl group on the benzene ring of the core has the potential to form a key hydrogen bond interaction to the hinge region of the binding pocket and thus resulted in the most potent inhibitor, 19, with K-i values at 2.5 and 43.5 nM against Pim-1 and Pim-2, respectively. Compound 19 also exhibited an activity pro. le with a high degree of kinase selectivity. (C) 2008 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Medicinal

Structure activity optimization of 6H-pyrrolo[2,3-e][1,2,4]triazolo[4,3-a]pyrazines as Jak1 kinase inhibitors

Michael Friedman, Kristine E. Frank, Ana Aguirre, Maria A. Argiriadi, Heather Davis, Jeremy J. Edmunds, Dawn M. George, Jonathan S. George, Eric Goedken, Bryan Fiamengo, Deborah Hyland, Bin Li, Anwar Murtaza, Michael Morytko, Gagandeep Somal, Kent Stewart, Edit Tarcsa, Stacy Van Epps, Jeffrey Voss, Lu Wang, Kevin Woller, Neil Wishart

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)

Article Chemistry, Medicinal

Synthesis and Biological Characterization of Aryl Uracil Inhibitors of Hepatitis C Virus NS5B Polymerase: Discovery of ABT-072, a trans-Stilbene Analog with Good Oral Bioavailability

John T. Randolph, A. Chris Krueger, Pamela L. Donner, John K. Pratt, Dachun Liu, Christopher E. Motter, Todd W. Rockway, Michael D. Tufano, Rolf Wagner, Hock B. Lim, Jill M. Beyer, Rubina Mondal, Neeta S. Panchal, Lynn Colletti, Yaya Liu, Gennadiy Koev, Warren M. Kati, Lisa E. Hernandez, David W. A. Beno, Kenton L. Longenecker, Kent D. Stewart, Emily O. Dumas, Akhteruzzaman Molla, Clarence J. Maring

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Chemistry, Medicinal

Non-peptide entry inhibitors of HIV-1 that target the gp41 coiled coil pocket

Kent D. Stewart, Jeffrey R. Huth, Teresa I. Ng, Keith McDaniel, Rebecca Newlin Hutchinson, Vincent S. Stoll, Renaldo R. Mendoza, Edmund D. Matayoshi, Robert Carrick, HongMei Mo, Jean Severin, Karl Walter, Paul L. Richardson, Leo W. Barrett, Robert Meadows, Steve Anderson, William Kohlbrenner, Clarence Maring, Dale J. Kempf, Akhter Molla, Edward T. Olejniczak

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)

Article Chemistry, Medicinal

Imidazo[2,1-b]thiazoles: Multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinases

Steve D. Fidanze, Scott A. Erickson, Gary T. Wang, Robert Mantei, Richard F. Clark, Bryan K. Sorensen, Nwe Y. Bamaung, Peter Kovar, Eric F. Johnson, Kerren K. Swinger, Kent D. Stewart, Qian Zhang, Lora A. Tucker, William N. Pappano, Julie L. Wilsbacher, Jieyi Wang, George S. Sheppard, Randy L. Bell, Steven K. Davidsen, Robert D. Hubbard

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)

Article Chemistry, Medicinal

Hepatitis C NS5B polymerase inhibitors: Functional equivalents for the benzothiadiazine moiety

Douglas K. Hutchinson, Charles A. Flentge, Pamela L. Donner, Rolf Wagner, Clarence J. Maring, Warren M. Kati, Yaya Liu, Sherie V. Masse, Tim Middleton, Hongmei Mo, Debra Montgomery, Wen W. Jiang, Gennadiy Koev, David W. A. Beno, Kent D. Stewart, Vincent S. Stoll, Akhteruzzaman Molla, Dale J. Kempf

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)

Article Chemistry, Medicinal

Discovery of potent and selective thienopyrimidine inhibitors of Aurora kinases

William J. McClellan, Yujia Dai, Cele Abad-Zapatero, Daniel H. Albert, Jennifer J. Bouska, Keith B. Glaser, Terry J. Magoc, Patrick A. Marcotte, Donald J. Osterling, Kent D. Stewart, Steven K. Davidsen, Michael R. Michaelides

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)

Article Chemistry, Medicinal

Exploration of diverse hinge-binding scaffolds for selective Aurora kinase inhibitors

Zhiqin Ji, Yujia Dai, Cele Abad-Zapatero, Daniel H. Albert, Jennifer J. Bouska, Keith B. Glaser, Patrick A. Marcotte, Nirupama B. Soni, Terry J. Magoc, Kent D. Stewart, Ru-Qi Wei, Steve K. Davidsen, Michael R. Michaelides

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)

Article Chemistry, Medicinal

Pyrazole diaminopyrimidines as dual inhibitors of KDR and Aurora B kinases

Michael L. Curtin, H. Robin Heyman, Robin R. Frey, Patrick A. Marcotte, Keith B. Glaser, James R. Jankowski, Terrance J. Magoc, Daniel H. Albert, Amanda M. Olson, David R. Reuter, Jennifer J. Bouska, Debra A. Montgomery, Joann P. Palma, Cherrie K. Donawho, Kent D. Stewart, Chris Tse, Michael R. Michaelides

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)

Article Chemistry, Medicinal

Hit to Lead optimization of a novel class of squarate-containing polo-like kinases inhibitors

Qingwei Zhang, Zhiren Xia, Michael J. Mitten, Loren M. Lasko, Vered Klinghofer, Jennifer Bouska, Eric F. Johnson, Thomas D. Penning, Yan Luo, Vincent L. Giranda, Alexander R. Shoemaker, Kent D. Stewart, Stevan W. Djuric, Anil Vasudevan

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)

Article Chemistry, Medicinal

Contribution of indazolinone tautomers to kinase activity

Anil Vasudevan, Mary K. Verzal, Clara I. Villamil, Kent D. Stewart, Cele Abad-Zapatero, Tetsuro Oie, Stevan W. Djuric

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)

Article Chemistry, Medicinal

Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase families

Michael L. Curtin, Robin R. Frey, H. Robin Heyman, Niru B. Soni, Patrick A. Marcotte, Lori J. Pease, Keith B. Glaser, Terrance J. Magoc, Paul Tapang, Daniel H. Albert, Donald J. Osterling, Amanda M. Olson, Jennifer J. Bouska, Zhiwen Guan, Lee C. Preusser, James S. Polakowski, Kent D. Stewart, Chris Tse, Steven K. Davidsen, Michael R. Michaelides

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)

Article Chemistry, Medicinal

Design and synthesis of tricyclic cores for kinase inhibition

Stacy Van Epps, Bryan Fiamengo, Jeremy Edmunds, Anna Ericsson, Kristine Frank, Michael Friedman, Dawn George, Jonathan George, Eric Goedken, Brian Kotecki, Gloria Martinez, Philip Merta, Michael Morytko, Shashank Shekhar, Barbara Skinner, Kent Stewart, Jeffrey Voss, Grier Wallace, Lu Wang, Lu Wang, Neil Wishart

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)

Article Chemistry, Medicinal

Aryl uracil inhibitors of hepatitis C virus NS5B polymerase: Synthesis and characterization of analogs with a fused 5,6-bicyclic ring motif

A. Chris Krueger, John T. Randolph, David A. DeGoey, Pamela L. Donner, Charles A. Flentge, Douglas K. Hutchinson, Dachun Liu, Christopher E. Motter, Todd W. Rockway, Rolf Wagner, David W. A. Beno, Gennadiy Koev, Hock B. Lim, Jill M. Beyer, Rubina Mondal, Yaya Liu, Warren M. Kati, Kenton L. Longenecker, Akhteruzzaman Molla, Kent D. Stewart, Clarence J. Maring

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)

Article Chemistry, Medicinal

Cheminformatic Tools for Medicinal Chemists

Steven W. Muchmore, Jeremy J. Edmunds, Kent D. Stewart, Philip J. Hajduk

JOURNAL OF MEDICINAL CHEMISTRY (2010)

Article Chemistry, Medicinal

Azaindole-Based Inhibitors of Cdc7 Kinase: Impact of the Pre-DFG Residue, Val 195

Yunsong Tong, Kent D. Stewart, Alan S. Florjancic, John E. Harlan, Philip J. Merta, Magdalena Przytulinska, Nirupama Soni, Kerren K. Swinger, Haizhong Zhu, Eric F. Johnson, Alexander R. Shoemaker, Thomas D. Penning

ACS MEDICINAL CHEMISTRY LETTERS (2013)

Article Chemistry, Medicinal

Design and synthesis of a library of C2-substituted sulfamidoadenosines to probe bacterial permeability

Shibin Zhao, Julian Maceren, Mia Chung, Samantha Stone, Raphael Geiben, Melissa L. Boby, Bradley S. Sherborne, Derek S. Tan

Summary: Antibiotic resistance is a major threat to public health, with Gram-negative bacteria presenting unique challenges due to their low permeability and efflux pumps. Limited understanding of the chemical rules for overcoming these barriers hinders antibacterial drug discovery. Efforts to address this issue, such as screening compound libraries and using cheminformatic analysis, have led to the design of sulfamidoadenosines with diverse substituents, showing potential utility in accumulation in Escherichia coli.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Design of MERS-CoV entry inhibitory short peptides based on helix-stabilizing strategies

Jichun Li, Qing Li, Shuai Xia, Jiahuang Tu, Longbo Zheng, Qian Wang, Shibo Jiang, Chao Wang

Summary: This study successfully developed a short peptide mimetic as a MERS-CoV fusion inhibitor by reproducing the key recognition features of the HR2 helix. The resulting 23-mer lipopeptide showed comparable inhibitory effect to the 36-mer HR2 peptide HR2P-M2. This has important implications for developing short peptide-based antiviral agents to treat MERS-CoV infection.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Development of novel β2-adrenergic receptor agonists for the stimulation of glucose uptake - The importance of chirality and ring size of cyclic amines

Krista Jaunsleine, Linda Supe, Jana Spura, Sten van Beek, Anna Sandstrom, Jessica Olsen, Carina Halleskog, Tore Bengtsson, Ilga Mutule, Benjamin Pelcman

Summary: Beta(2)-adrenergic receptor agonists can stimulate glucose uptake by skeletal muscle cells and are therefore potential treatments for type 2 diabetes. The chirality of compounds has a significant impact on the activity of these agonists. This study found that certain synthesized compounds showed higher glucose uptake activity. These findings provide important information for the design of novel beta(2)AR agonists for T2D treatment.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Conformationally constrained potent inhibitors for enhancer of zeste homolog 2 (EZH2)

Xin Xu, Jia Chen, Guan Wang, Xiaojuan Zhang, Qiang Li, Xiaobo Zhou, Fengying Guo, Min Li

Summary: The study focuses on EZH2, a promising therapeutic target for various types of cancers. Researchers designed and synthesized a series of novel derivatives aiming to enhance the EZH2 inhibition activity. Among them, compound 28 displayed potent EZH2 inhibition activity and showed high anti-proliferative effects in lymphoma cell lines and xenograft mouse models. The study suggests that compound 28 has potential as a therapeutic candidate for EZH2-associated cancers.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

The potential of Rhein's aromatic amines for Parkinson's disease prevention and treatment: α-Synuclein aggregation inhibition and disaggregation of preformed fibers

Wei Zhang, Wei Liu, Ya-Dong Zhao, Li-Zi Xing, Ji Xu, Rui-Jun Li, Yun-Xiao Zhang

Summary: This study developed a series of aromatic amide derivatives based on Rhein and investigated their inhibitory activity against alpha-Syn aggregation. Two of these compounds showed promising potential in treating Parkinson's disease by stabilizing alpha-Syn's conformation and disassembling alpha-Syn oligomers and fibrils.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Design, synthesis and biological evaluation of novel cationic liposomes loaded with melphalan for the treatment of cancer

Mani Sharma, S. S. S. S. Sudha Ambadipudi, Neeraj Kumar Chouhan, V. Lakshma Nayak, Srihari Pabbaraja, Sai Balaji Andugulapati, Ramakrishna Sistla

Summary: Therapeutically active lipids in drug delivery systems can enhance the safety and efficacy of treatment. The liposome formulation created using synthesized biologically active lipids showed additive anti-cancer effects and reduced tumorigenic potential.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)